4.6 Review

Systematic review of cognitive event related potentials in euthymic bipolar disorder

Journal

CLINICAL NEUROPHYSIOLOGY
Volume 129, Issue 9, Pages 1854-1865

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.clinph.2018.05.025

Keywords

Bipolar disorder; Cognition; ERP; EEG

Funding

  1. Johnson Johnson
  2. AstraZeneca
  3. Lundbeck
  4. Bristol-Myers Squibb
  5. Johnson Jonson
  6. Eli Lilly
  7. Fonds voor Wetenschappelijk Onderzoek (IWT) - Flanders
  8. Fonds voor Wetenschappelijk Onderzoek (Hercules) - Flanders

Ask authors/readers for more resources

Cognitive deficits are critical features of bipolar disorder (BD), greatly impacting quality of life. The aim is to systematically review and critically evaluate underlying event related potential (ERP) features in euthymic BD relating to differences in sensory processes, attention, inhibition and conflict monitoring compared with healthy controls. 911 unique articles were identified using the PubMed database and 14 studies met the inclusion criteria. Individuals with BD in a euthymic state have reduced P50 sensory gating and reduced P100 amplitudes compared with healthy controls. Many studies demonstrated reduced P300 amplitudes and normal P300 latencies in BD. In addition, reduced NoGo N2 and abnormal NoGo P3 activity were observed in BD. Finally, there is some evidence of reduced error-related negativity amplitudes in BD. Importantly, ERP modulations vary with stimulus factors and clinical profile. The functional significance of these findings and clinical implications are discussed. ERP differences in BD arise at various stages of cognitive processing, specifically in early auditory and visual processing, attention allocation, context updating, inhibition and conflict monitoring. Treating these deficits and their underlying neurobiological disturbances corresponding to abnormal performance on cognitive tasks may aid functional remission. This knowledge might enable personalized treatment interventions targeting specific cognitive deficits. (C) 2018 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available